Viewing Study NCT00093002


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2026-03-03 @ 3:05 PM
Study NCT ID: NCT00093002
Status: COMPLETED
Last Update Posted: 2008-06-12
First Post: 2004-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module